APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias
Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias Who Need Cardiac Pacing
Sponsor: Medtronic
This NA trial investigates Tachyarrhythmia and is currently completed. Medtronic leads this study, which shows 8 recorded versions since 2000 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
-
Jul 2025 — Aug 2025 [monthly]
Completed NA
-
Sep 2024 — Jul 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Feb 2018 — Jun 2018 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Jan 2017 — Feb 2018 [monthly]
Completed PHASE4
First recorded
Aug 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic
- Medtronic Cardiac Rhythm and Heart Failure
For direct contact, visit the study record on ClinicalTrials.gov .